Abstract
The Dolan study shows that establishment of a methadone treatment clinic for women in Tehran, Iran, is a significant step toward addressing an urgent need: if the access threshold for services is lowered, uptake among female drug users is dramatic. Implementation of effective harm reduction and other HIV prevention for women should interest policymakers, program managers, and providers in the drug prevention, treatment, and rehabilitation community, and in the HIV community at large – in and beyond Iran.Original Article JPHP.2011.10, available at www.palgrave-journals.com/jphp/, relates to this Commentary.
References
United Nations Office on Drugs and Crime. (2006) HIV/AIDS Prevention and Care for Female Injecting Drug Users. Vienna, Austria: United Nations Office on Drugs and Crime.
Burrows D for AIDS Projects Management Group. (2004) Women and Injecting Drug Use, HIV and Harm Reduction: An Analysis of Peer Reviewed Literature, Concentrating on Developing Countries, The POLICY Project. Mawson: Burrows D for AIDS Projects Management Group, November 2004.
El-Bassel, N., Terlikbaeva, A. and Pinkham, S. (2010) HIV and women who use drugs: Double neglect, double risk. The Lancet 376 (9738): 312–314.
Pinkham, S. and Malinowska-Sempruch, K. (2007) Women, Harm Reduction, and HIV. New York: Open Society Institute's International Harm Reduction Development Program.
Dolan, K., Salimi, S., Nassirimanesh, B., Mohsenifar, S. and Mokri, A. (2011) The establishment of a methadone treatment clinic for women in Tehran, Iran. Journal of Public Health Policy. Advance online publication 10 March, doi:10.1057/jphp.2011.10.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Claeson, M. Commentary: Reaching women drug users with methadone treatment and other HIV prevention services in Tehran. J Public Health Pol 32, 231–233 (2011). https://doi.org/10.1057/jphp.2011.11
Published:
Issue Date:
DOI: https://doi.org/10.1057/jphp.2011.11